Seller record · Telehealth service

Coby Health

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The terms, company and medication pages refer to partner pharmacies without naming the dispensing facility. 1 more criterion also fails; see the table below.

At a glance

Coby HealthTelehealth service

5/8criteria passed
Price
Printed on its own pages before sign-up
Sells
compounded semaglutide, compounded tirzepatide, sermorelin, and 1 more
FDA letters
None on file
Visit Coby HealthSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A telehealth marketplace offering compounded GLP-1 treatments with dose-specific monthly pricing and prepaid options, alongside sermorelin and other prescription wellness treatments.

Operating entity Coby Health LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSCoby Health's website; Coby Health's semaglutide product page
S2Prescription gatingNOT VERIFIEDCoby Health's help page; Coby Health's terms of service page
S3Pharmacy identificationFAILCoby Health's terms of service page; Coby Health's semaglutide product page
S4Compounding disclosurePASSCoby Health's semaglutide product page
S5Analytical documentationFAILCoby Health's semaglutide product page; Coby Health's safety information page
S6Business addressPASSCoby Health's terms of service page; Coby Health's privacy policy
S7Price disclosurePASSCoby Health's semaglutide product page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSIndependent healthcare providers evaluate patients and determine prescriptions, and the semaglutide page requires medical supervision and an individualized treatment plan.Source: Coby Health's website; Coby Health's semaglutide product page.
S2NOT VERIFIEDThe payment-sequence question did not resolve from the published material. The public pages require provider approval but do not establish whether payment is collected before medical evaluation. The help page describes charges for visits that are not approved. The check is open.Source: Coby Health's help page; Coby Health's terms of service page.
S3FAILThe terms, company and medication pages refer to partner pharmacies without naming the dispensing facility.Source: Coby Health's terms of service page; Coby Health's semaglutide product page.
S4PASSThe semaglutide product page states that compounded semaglutide has not been approved by the FDA and is not equivalent to FDA-approved products.Source: Coby Health's semaglutide product page.
S5FAILThe medication and safety pages publish no certificate of analysis or equivalent lot document.Source: Coby Health's semaglutide product page; Coby Health's safety information page.
S6PASSThe terms identify Northwest Registered Agent Service at 2501 Chatham Rd Ste N, Springfield, IL 62704-4188 as the notice address. The privacy policy uses the same address for Coby Health.Source: Coby Health's terms of service page; Coby Health's privacy policy.
S7PASSIntroductory monthly semaglutide starts at $159 with $199 crossed out, then the dose table lists $199 for month two, $229 for month three and $249 from month four. A three-month option is $399 with $627 crossed out.Source: Coby Health's semaglutide product page.
S8PASSNo FDA warning letter names Coby Health or Coby Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin, NAD+.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+

Visit Coby Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.